Effect of maternal zinc supplementation on the cardiometabolic profile of Peruvian children: Results from a randomized clinical trial

Journal of Developmental Origins of Health and Disease

Volumn 8, Issue 1, 2017, Pages 56-64

  Mispireta, M L ^a,b   Caulfield, L E ^b   Zavaleta, N ^c   Merialdi, M ^d   Putnick, D L ^e   Bornstein, M H ^e   DiPietro, J A ^b  

^a IDAHO STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTO DE INVESTIGACIÓN NUTRICIONAL   (Peru)

^d BD Technologies   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

cardiovascular; metabolic; zinc

Indexed keywords

ZINC;

ADULT; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED STUDY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; HUMAN; MALE; MATERNAL NUTRITION; METABOLIC SYNDROME X; NEWBORN; PERU; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; CARDIOVASCULAR DISEASES; CHILD; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC SYNDROME; PERU; PREGNANCY; YOUNG ADULT; ZINC;

EID: 84991717403     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174416000568     Document Type: Article

References (56)

1. World Health Organization. (ed.) Global Status Report on Noncommunicable Diseases. 2014. WHO: Geneva.
2. Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993; 341, 938-941.
3. Barker DJ. The developmental origins of insulin resistance. Horm Res. 2005; 64(Suppl. 3), 2-7.
4. Christian P, Stewart CP. Maternal micronutrient deficiency, fetal development, and the risk of chronic disease. J Nutr. 2010; 140, 437-445.
5. Tomat A, Inserra F, Veiras L, et al. Moderate zinc restriction during fetal and postnatal growth of rats: effects on adult arterial blood pressure and kidney. Am J Physiol Regul Comp Physiol. 2008; 295, R543-R549.
6. Padmavathi IJ, Kishore YD, Venu L, et al. Prenatal and perinatal zinc restriction: effects on body composition, glucose tolerance and insulin response in rat offspring. Exp Physiol. 2009; 94, 761-769.
7. Stewart CP, Christian P, Schulze KJ, et al. Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal. J Nutr. 2009; 139, 1575-1581.
8. Stewart CP, Christian P, LeClerq SC, West KP, Khatry SK. Antenatal supplementation with folic acid + iron + zinc improves linear growth and reduces peripheral adiposity in school-age children in rural Nepal. Am J Clin Nutr. 2009; 90, 132-140.
9. Caulfield LE, Zavaleta N, Shankar AH, Merialdi M. Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr. 1998; 68(Suppl. 2), 499S-508S.
10. Lee SE, Talegawkar SA, Merialdi M, Caulfield LE. Dietary intakes of women during pregnancy in low- and middle-income countries. Public Health Nutr. 2013; 16, 1340-1353.
11. Sacco LM, Caulfield LE, Zavaleta N, Retamozo L. Dietary pattern and usual nutrient intakes of Peruvian women during pregnancy. Eur J Clin Nutr. 2003; 57, 1492-1497.
12. Caulfield LE, Zavaleta N, Figueroa A. Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population. Am J Clin Nutr. 1999; 69, 1257-1263.
13. Caulfield LE, Donangelo CM, Chen P, et al. Red blood cell metallothionein as an indicator of zinc status during pregnancy. Nutrition. 2008; 24, 1081-1087.
14. Merialdi M, Caulfield LE, Zavaleta N, et al. Randomized controlled trial of prenatal zinc supplementation and fetal bone growth. Am J Clin Nutr. 2004; 79, 826-830.
15. Merialdi M, Caulfield LE, Zavaleta N, et al. Randomized controlled trial of prenatal zinc supplementation and the development of fetal heart rate. Am J Obstet Gynecol. 2004; 190, 1106-1112.
16. Caulfield LE, Zavaleta N, Chen P, et al. Maternal zinc supplementation during pregnancy affects autonomic function of Peruvian children assessed at 54 months of age. J Nutr. 2011; 141, 327-332.
17. Camhi SM, Katzmarzyk PT. Tracking of cardiometabolic risk factor clustering from childhood to adulthood. Int J Pediatr Obes. 2010; 5, 122-129.
18. Caulfield LE, Putnick DL, Zavaleta N, et al. Maternal gestational zinc supplementation does not influence multiple aspects of child development at 54 mo of age in Peru. Am J Clin Nutr. 2010; 92, 130-136.
19. Lohman T, Roche A, Martorell R. Anthropometric Standardization Reference Manual. 1988; p. 18. Human Kinetics Pub: Champaign, IL.
20. World Health Organization. WHO Child Growth Standards: Methods and Development: Length/Height-For-Age, Weight-For-Age, Weight-For-Length, Weight-For-Height and Body Mass Index-For-Age. 2006. WHO: Geneva.
21. Boutton TW, Trowbridge FL, Nelson MM, et al. Body composition of Peruvian children with short stature and high weight-for-height. I. Total body-water measurements and their prediction from anthropometric values. Am J Clin Nutr. 1987; 45, 513-525.
22. Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Cholesterol Education Program (NCEP) highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992; 89, 495-501.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18, 499-502.
24. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28, 412-419.
25. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958; 26, 24-36.
26. Tukey J. Exploratory Data Analysis. 1977. Addison-Wesley: Reading, MA.
27. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285, 2486-2497.
28. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004; 145, 439-444.
29. Daniels SR, Greer FR, Nutrition Co. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122, 198-208.
30. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(Suppl. 2 4th Report), 555-576.
31. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014; 37(Suppl. 1), S14-S80.
32. Ferguson C. An effect size primer: a guide for clinicians and researchers. Prof Psychol Res Pr. 2009; 40, 532-538.
33. Hawkesworth S, Wagatsuma Y, Kahn AI, et al. Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh. J Nutr. 2013; 143, 728-734.
34. Vaidya A, Saville N, Shrestha BP, et al. Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial. Lancet. 2008; 371, 492-499.
35. Singh RB, Niaz MA, Rastogi SS, et al. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr. 1998; 17, 564-570.
36. Li Y, Guo H, Wu M, Liu M. Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China. Asia Pac J Clin Nutr. 2013; 22, 60-68.
37. Sun Q, van Dam RM, Willett WC, Hu FB. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care. 2009; 32, 629-634.
38. Vashum KP, McEvoy M, Shi Z, et al. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women's health. BMC Endocr Disord. 2013; 13-40.
39. Capdor J, Foster M, Petocz P, Samman S. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol. 2013; 27, 137-142.
40. Jayawardena R, Ranasinghe P, Galappatthy P, et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012; 4, 13.
41. Foster M, Petocz P, Samman S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis. 2010; 210, 344-352.
42. Kuchmak M, Taylor L, Olansky AS. Suitability of frozen and lyophilized reference sera for cholesterol and triglyceride determinations. Clin Chim Acta. 1982; 120, 261-271.
43. Tiedink HG, Katan MB. Variability in lipoprotein concentrations in serum after prolonged storage at -20 degrees C. Clin Chim Acta. 1989; 180, 147-155.
44. Meigs JB, Haffner SM, Nathan DM, D'Agostino RB, Wilson PW. Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study. J Clin Epidemiol. 2001; 54, 1031-1036.
45. Haney EM, Huffman LH, Bougatsos C, et al. Screening for Lipid Disorders in Children and Adolescents. 2007. Agency for Healthcare Research and Quality (US): Rockville, MD.
46. Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2009; 24, 707-719.
47. Buse JB, Kaufman FR, Linder B, et al. Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middle-school cohort. Diabetes Care. 2013; 36, 429-435.
48. Evelein AM, Visseren FL, van der Ent CK, Grobbee DE, Uiterwaal CS. Excess early postnatal weight gain leads to increased abdominal fat in young children. Int J Pediatr. 2012; 2012, 1410656.
49. Evelein AM, Visseren FL, van der Ent CK, Grobbee DE, Uiterwaal CS. Excess early postnatal weight gain leads to thicker and stiffer arteries in young children. J Clin Endocrinol Metab. 2013; 98, 794-801.
50. Ong KK, Petry CJ, Emmett PM, et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia. 2004; 47, 1064-1070.
51. Iannotti LL, Zavaleta N, León Z, Caulfield LE. Growth and body composition of Peruvian infants in a periurban setting. Food Nutr Bull. 2009; 30, 245-253.
52. Chen W, Bao W, Begum S, et al. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes. 2000; 49, 1042-1048.
53. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998; 20, 157-172.
54. Corvalán C, Uauy R, Kain J, Martorell R. Obesity indicators and cardiometabolic status in 4-y-old children. Am J Clin Nutr. 2010; 91, 166-174.
55. Cowin I, Emmett P. Cholesterol and triglyceride concentrations, birthweight and central obesity in pre-school children. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Int J Obes Relat Metab Disord. 2000; 24, 330-339.
56. Williams CL, Strobino B, Bollella M, Brotanek J. Body size and cardiovascular risk factors in a preschool population. Prev Cardiol. 2004; 7, 116-121.